Trial · NCT03268811
Results by group169
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 169
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | Total Children (Aged: 1 to 15 Years) | 7 | Participants | ||
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | Infants (Corrected Gestational Age: 4 to < 12 Months) | 2 | Participants | ||
| Number of Participants With Clinically Significant Abnormalities in Vital Signs | Total Children (Aged: 1 to 15 Years) | 0 | Participants | ||
| Number of Participants With Clinically Significant Abnormalities in Vital Signs | Infants (Corrected Gestational Age: 4 to < 12 Months) | 0 | Participants | ||
| Number of Participants With Clinically Significant Abnormalities in Laboratory Parameters | Total Children (Aged: 1 to 15 Years) | Biochemistry | 5 | Participants | |
| Number of Participants With Clinically Significant Abnormalities in Laboratory Parameters | Infants (Corrected Gestational Age: 4 to < 12 Months) | Biochemistry | 1 | Participants | |
| Number of Participants With Clinically Significant Abnormalities in Laboratory Parameters | Total Children (Aged: 1 to 15 Years) | Hematology | 1 | Participants | |
| Number of Participants With Clinically Significant Abnormalities in Laboratory Parameters | Infants (Corrected Gestational Age: 4 to < 12 Months) | Hematology | 0 | Participants | |
| Number of Participants With Clinically Significant Abnormalities in Laboratory Parameters | Total Children (Aged: 1 to 15 Years) | Urinalysis. | 0 | Participants | |
| Number of Participants With Clinically Significant Abnormalities in Laboratory Parameters | Infants (Corrected Gestational Age: 4 to < 12 Months) | Urinalysis. | 0 | Participants | |
| Percent Change From Baseline in Average Total Urine Output at End of Treatment (EOT) of Last Cycle During Teduglutide Treatment | Total Children (Aged: 1 to 15 Years) | -37.228 | Standard Deviation 42.9396 | Percent change | |
| Percent Change From Baseline in Average Total Urine Output at End of Treatment (EOT) of Last Cycle During Teduglutide Treatment | Infants (Corrected Gestational Age: 4 to < 12 Months) | 146.881 | Standard Deviation 295.8061 | Percent change | |
| Percent Change From Baseline in Average Number of Stools Per Day at EOT of Last Cycle During Teduglutide Treatment | Total Children (Aged: 1 to 15 Years) | 24.37 | Standard Deviation 63.623 | Percent change | |
| Percent Change From Baseline in Average Number of Stools Per Day at EOT of Last Cycle During Teduglutide Treatment | Infants (Corrected Gestational Age: 4 to < 12 Months) | 50.00 | Standard Deviation 0.000 | Percent change | |
| Percent Change From Baseline in Average Stool/Mixed Stool Diaper Weight at EOT of Last Cycle During Teduglutide Treatment | Total Children (Aged: 1 to 15 Years) | -12.678 | Standard Deviation NA | Percent change | |
| Percent Change From Baseline in Average Stool/Mixed Stool Diaper Weight at EOT of Last Cycle During Teduglutide Treatment | Infants (Corrected Gestational Age: 4 to < 12 Months) | 206.017 | Standard Deviation 332.4580 | Percent change | |
| Percent Change From Baseline in Average Total Ostomy Output at EOT of Last Cycle During Teduglutide Treatment | Infants (Corrected Gestational Age: 4 to < 12 Months) | 3.143 | Standard Deviation 145.8659 | Percent change | |
| Percent Change From Baseline in Average Bristol Stool Form Score at EOT of Last Cycle During Teduglutide Treatment | Total Children (Aged: 1 to 15 Years) | -7.51 | Standard Deviation 16.758 | Percent change | |
| Percent Change From Baseline in Average Bristol Stool Form Score at EOT of Last Cycle During Teduglutide Treatment | Infants (Corrected Gestational Age: 4 to < 12 Months) | 0.00 | Standard Deviation 0.000 | Percent change | |
| Number of Participants With Anti-drug Antibodies (ADAs) (Including Neutralizing Antibodies) at EOT of Last Cycle During Teduglutide Treatment | Total Children (Aged: 1 to 15 Years) | Positive ADA at EOT of the Last Cycle | 5 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03268811/results